Summary
The first objective of this study was to analyze the survival rate in a group of 69 breast cancers detected among nonattenders in a randomized mammographic screening trial in relation to 142 clinically detected cancers in a nonscreened control population. By analyzing the cancers of the nonattenders we identified two subgroups, one (A) had actively avoided mammography, had cancers in more advanced stages on diagnosis, and had significantly higher mortality from breast cancer than the control group (p = 0.003). The second subgroup (B) had mammography done outside the screening program. This subgroup had a nonsignificant, slightly better survival (p = 0.19) compared to the control group. Concerning stage the cancers in group B were similar to the cancers by the screening program.
The second objective was to analyze women's reasons for nonattendance in the screening program. We interviewed 200 randomly selected nonattenders; 33% stated that they never could imagine having mammography (definite nonattenders), 29.5% that they for various reasons had missed the mammography but could imagine having it next time (possible future attenders), and 32% had been examined outside the program. Reasons for nonattendance included disinterest, medical problems, and fear of X-rays. From this interview investigation we believe that the subgroup of definite nonattenders (33%) is difficult to influence. The second subgroup classified as possible future attenders (29.5%) we believe can be influenced by more information and a new opportunity to receive mammography, i.e., a reminder letter. The third subgroup, those examined outside the screening program (32%) were aware of the benefit of mammography, taking action on their own. Concerning these women's health this seems acceptable; screening outside the program seemed equivalent to that inside the program concerning stage and mortality in breast cancer as shown in the first part of the study.
This is a preview of subscription content, log in via an institution to check access.
References
Day N, Williams D, Khaw K: Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59: 954–958, 1989
Tabár L, Fagerberg C, Duffy S, Day N: Recent results from the Swedish two-county trials of mammographic screening for breast cancer. J Epidem Comm Hlth 43: 107–114, 1989
Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfusson B: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. Br Med J 297: 943–948, 1988
Shapiro S, Strax P, Venet L: Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 215: 1777–1785, 1971
Tabár L, Gad A: Screening for breast cancer: The Swedish trial. Radiology 138: 219–222, 1981
Frisell J, Glas U, Hellström L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Design, first rounds results, and comparisons. Breast Cancer Res Treat 8: 45–54, 1986
Palli D, Rosselli del Turco M, Buiatti E, Carli S, Ciatto S, Toscani L, Maltoni G: A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 38: 501–504, 1986
Roberts M, Alexander F, Anderson T, Forrest A, Hepburn W, Huggins A, Kirkpatrick A, Lamb J, Lutz W, Muir B: The Edinburgh randomised trial of screening for breast cancer: Description of method. Br J Cancer 50: 1–6, 1984
U K Trial, Early Detection of Breast Cancer Group. Trial of early detection of breast cancer: description of method. Br J Cancer 44: 618–627, 1981
Verbeek A, Holland R, Sturmans F, Hendriks J, Mravunac M, Day N: Reduction of breast cancer mortality through mass screening with modern mammography. Lancet 2: 1222–1224, 1984
Lundgren B: Population screening for breast cancer by single view mammography in a geographic region in Sweden. J Natl Cancer Inst 62: 1373–1379, 1979
Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist L-E, Somell A: Randomized study of mammographic screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56, 1991
Frisell J, Eklund G, Hellström L, Glas U, Somell A: The Stockholm breast cancer screening trial - 5-year results and stage at discovery. Breast Cancer Res Treat 13: 79–87, 1989
Armitage P, Berry G: Statistical Methods in Medical Research (Blackwell Scientific Publications): 14.2: 422-428, 14.6: 429-433, 8.1: 214-222, 4.4: 106-109, 1987
Donato F, Bollani A, Spiazzi R, Pasquale L, Monarca L, Lucini L, Nardi G: Factors associated with non-participation of women in a breast cancer screening programme in a town in northern Italy. Journal of Epidemiology and Community Health 45: 59–64, 1991
Rutledge D, Hartmann W, Kinman P, Winfield A: Exploration of factors affecting mammography behaviors. Preventive Medicine 17: 412–422, 1988
U.K. Trial, Early Detection of Breast Cancer Group: First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet 2: 411–416, 1988
Tabár L, Fagerberg G, Gad A, Baldetorp L, Holmberg L, Gröntoft D, Ljungkvist U, Lundström B, Månsson I, Eklund G, Pettersson F, Day N: Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1: 829–832, 1985
Fink R, Shapiro S, Roeser R: Impacts of efforts to increase participation in repetetive screenings for early breast cancer detection. Amer J Public Health 62: 328–336, 1972
Hobbs P, Smith A, George WD, Sellwood RA: Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. Journal of Epidemiology and Community Health 34: 19–22, 1980
Rimer BK, Kasper Keintz M, Kessler HB, Engstrom PF, Rosan JR: Why women resist screening mammography: patient related barriers. Radiology 172: 243–246, 1989
Lerman G, Rimer B, Trock B, Balshem A, Engstrom PF: Factors associated with repeated adherence to breast cancer screening. Prev Med 19: 279–290, 1990
Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: psychosocial and ethical implications. Journal of Clinical Oncology 9: 1275–1282, 1991
Rosenstock IM: The health belief model and preventive health behaviour. Health Education Monographs 345-386, 1975
Peeters PHM, Verbeek ALM, Hendriks J, van Bon M: Screening for breast cancer in Nijmegen. Report of 6 screening rounds. Int J Cancer 43: 226–230, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lidbrink, E., Frisell, J., Brandberg, Y. et al. Nonattendance in the Stockholm mammography screening trial: Relative Mortality and reasons for nonattendance. Breast Cancer Res Tr 35, 267–275 (1995). https://doi.org/10.1007/BF00665978
Issue Date:
DOI: https://doi.org/10.1007/BF00665978